ASI Optimizes Data Collection for Medical Devices

Medical device manufacturers operate under some of the most stringent quality and regulatory requirements in any industry, where data integrity directly affects patient safety and FDA compliance. ASI (Advanced Systems Integration) faced a critical challenge: manual data collection processes across their medical device production workflows introduced unacceptable risk of human error, transcription mistakes, and audit trail gaps. In an environment where every production parameter must be traceable and defensible during regulatory inspections, paper-based or disconnected data entry creates compliance exposure and slows throughput. The operational overhead of manual collection also diverted skilled technicians from higher-value work.

ASI partnered with Rockwell Automation to implement an automated data collection solution tightly integrated with their medical device manufacturing workflows. The system replaced manual data entry points with automated capture tied directly to production equipment, eliminating transcription steps between the machine floor and quality records. Rockwell Automation's industrial automation platform served as the backbone, enabling real-time data acquisition from process equipment and routing structured records into downstream quality management systems. The integration connected existing production assets without requiring full line replacement, allowing ASI to modernize data collection incrementally. This approach ensured that critical production parameters — measurements, timestamps, operator actions — were captured automatically at the source, creating a reliable, tamper-evident audit trail aligned with FDA 21 CFR Part 11 requirements for electronic records.

The automated data collection implementation delivered measurable improvements in both accuracy and operational efficiency across ASI's medical device production lines. By eliminating manual transcription, the risk of data entry errors was substantially reduced — a critical outcome in a regulated environment where data integrity failures can trigger costly investigations or product holds. Key outcomes include:

• Improved data accuracy through automated capture directly from production equipment, removing human transcription as an error source
• Faster audit readiness with structured electronic records replacing paper-based logs
• Reduced technician burden, freeing skilled staff from repetitive data entry tasks
• Stronger compliance posture with traceable, timestamped production records meeting FDA electronic record standards

• Automated data collection is not optional in medical device manufacturing — manual processes create compliance risk that regulators and customers will not accept long-term.
• Integrating data capture at the equipment level, rather than bolting on data entry after the fact, is the only approach that reliably eliminates transcription error.
• Incremental integration with existing production assets reduces implementation risk and avoids costly line shutdowns during modernization.
• A clear audit trail from automated systems accelerates FDA inspections and internal quality reviews, reducing the operational cost of compliance.
• Partnering with an established industrial automation vendor ensures the infrastructure meets regulated-industry standards from the outset.